Clinical Trial

The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study

Study acronym: MAP-PFA
Completed
View on ClinicalTrials.gov →
Summary
This is a randomized control trial that aims to evaluate the added value of electro-anatomical mapping to improve the quality of pulse field ablation lesions during Atrial fibrillation ablation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-06; most recent amendment 2026-05-18.
Status change: Not Yet Recruiting → Completed 2026-01-21
Trial Details
NCT Number NCT07014423
Lead Sponsor University Medical Center Groningen
Conditions Atrial Fibrillation (AF)
Enrollment 32 participants
Start Date 2025-09-15
Primary Completion 2025-12-09 (estimated)
Study Completion 2026-01-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-20